NNovo Nordisk Read More Novo Nordisk Faces a High-Stakes Balancing Act: Wegovy Pill Approval vs. Escalating Cyber Threats2026-06-22 Novo Nordisk ended a week of stark contrasts with its shares stuck near EUR 38.90 — a modest…